Thomas C B, Nelson D O, Pleshanov P, Vorobstova I, Tureva L, Jensen R, Jones I M
Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory, L-452, P.O. Box 808, Livermore, CA 94550, USA.
Mutat Res. 1999 Feb 2;439(1):105-19. doi: 10.1016/s1383-5718(98)00179-x.
This study was conducted to determine whether the frequency of hypoxanthine phosphoribosyltransferase (HPRT) deficient lymphocyte mutants would detect an effect of radiation exposure in a population of Russians who were exposed to low levels of radiation while working in 1986 and 1987 as liquidators cleaning up after the Chernobyl nuclear power reactor accident. The HPRT lymphocyte cloning assay was performed on peripheral blood lymphocytes collected between 1992 and 1996 from 142 liquidators and 66 Russian controls, and between 1989 and 1993 from 231 American controls. Russian and American controls were not significantly different for either cloning efficiency or mutant frequency (MF); inclusion of both sets of controls in the analysis increased the ability to detect a Chernobyl exposure effect in the liquidators. After adjusting for age and smoking, the results revealed no significant difference in cloning efficiency of Chernobyl liquidators relative to Russian controls but a significant, 24% increase in liquidator HPRT mutant frequency over Russian controls (90% confidence interval was 7% to 45% increase). The analytical method also accounted for differences in precision of the individual estimates of log CE and log MF and accommodated for outliers. The increase in HPRT mutant frequency of liquidators is an attribute of the exposed population as a whole rather than of individuals. These results demonstrate that, under appropriate circumstances, the HPRT specific locus mutation assay of peripheral blood lymphocytes can be used to detect a semi-acute, low dose radiation exposure of a population, even 6 to 10 years after the exposure.
本研究旨在确定次黄嘌呤磷酸核糖基转移酶(HPRT)缺陷淋巴细胞突变体的频率是否能检测出1986年和1987年在切尔诺贝利核电站事故后作为清理人员接触低水平辐射的俄罗斯人群中辐射暴露的影响。对1992年至1996年从142名清理人员和66名俄罗斯对照者采集的外周血淋巴细胞,以及1989年至1993年从231名美国对照者采集的外周血淋巴细胞进行了HPRT淋巴细胞克隆测定。俄罗斯和美国对照者在克隆效率或突变频率(MF)方面均无显著差异;在分析中纳入两组对照者提高了检测清理人员中切尔诺贝利暴露影响的能力。在对年龄和吸烟情况进行调整后,结果显示,与俄罗斯对照者相比,切尔诺贝利清理人员的克隆效率无显著差异,但清理人员的HPRT突变频率相对于俄罗斯对照者显著增加了24%(90%置信区间为增加7%至45%)。该分析方法还考虑了对数CE和对数MF个体估计值的精度差异,并对异常值进行了处理。清理人员HPRT突变频率的增加是整个暴露人群的特征,而非个体特征。这些结果表明,在适当情况下,外周血淋巴细胞的HPRT特异性位点突变测定可用于检测人群的半急性、低剂量辐射暴露,即使在暴露后6至10年。